VOZ Advisors is assisting Takeda, a global pharmaceutical company, to gather insights from people living with IgA Nephropathy. Selected individuals will be asked to participate in a virtual patient advisory board to share their experience living with IgA Nephropathy and provide feedback on a variety of related topics. Insights from participants will help inform the Takeda IgA Nephropathy clinical program.
Consumer involvement in committee
Once- Virtual meetings
Yes - Paid
Email: email@example.comReturn to Research listing page